Top compounds associated with response to LCN8


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine gCSI pan-cancer AAC -0.17 0.002
mRNA necrostatin-1 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.002
mRNA alisertib CTRPv2 pan-cancer AAC 0.094 0.002
mRNA CHIR-99021 CTRPv2 pan-cancer AAC 0.1 0.002
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.098 0.003
mRNA silmitasertib CTRPv2 pan-cancer AAC 0.11 0.003
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.084 0.004
Download CSV